BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Z, Wang N, Yang L, Song X. Bioactive natural products in COVID-19 therapy. Front Pharmacol 2022;13:926507. [DOI: 10.3389/fphar.2022.926507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Khan SA, Lee TKW. Identifying potential pharmacological targets and molecular pathways of Meliae cortex for COVID-19 therapy. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1128164] [Reference Citation Analysis]
2 Kawall A, Lewis DSM, Sharma A, Chavada K, Deshmukh R, Rayalam S, Mody V, Taval S. Inhibitory effect of phytochemicals towards SARS-CoV-2 papain like protease (PLpro) proteolytic and deubiquitinase activity. Front Chem 2022;10:1100460. [PMID: 36712981 DOI: 10.3389/fchem.2022.1100460] [Reference Citation Analysis]
3 Semenov VA, Krivdin LB. The Development of Pharmacophore Models for the Search of New Natural Inhibitors of SARS-CoV-2 Spike RBD-ACE2 Binding Interface. Molecules 2022;27. [PMID: 36558067 DOI: 10.3390/molecules27248938] [Reference Citation Analysis]
4 Mudenda S, Mukosha M, Godman B, Fadare JO, Ogunleye OO, Meyer JC, Skosana P, Chama J, Daka V, Matafwali SK, Chabalenge B, Witika BA. Knowledge, Attitudes, and Acceptance of COVID-19 Vaccines among Secondary School Pupils in Zambia: Implications for Future Educational and Sensitisation Programmes. Vaccines (Basel) 2022;10. [PMID: 36560551 DOI: 10.3390/vaccines10122141] [Reference Citation Analysis]
5 Sirohi P, Verma H, Singh SK, Singh VK, Pandey J, Khusharia S, Kumar D, Kaushalendra, Teotia P, Kumar A. Microalgal Carotenoids: Therapeutic Application and Latest Approaches to Enhance the Production. Curr Issues Mol Biol 2022;44:6257-79. [PMID: 36547088 DOI: 10.3390/cimb44120427] [Reference Citation Analysis]
6 Wang Z, Yang L, Song XQ. Oral GS-441524 derivatives: Next-generation inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase. Front Immunol 2022;13:1015355. [PMID: 36561747 DOI: 10.3389/fimmu.2022.1015355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Halma MTJ, Wever MJA, Abeln S, Roche D, Wuite GJL. Therapeutic potential of compounds targeting SARS-CoV-2 helicase. Front Chem 2022;10:1062352. [PMID: 36561139 DOI: 10.3389/fchem.2022.1062352] [Reference Citation Analysis]
8 Yi Y, Fang J, Liu Y, Gao Y, Lin W, Hao D, Zhang X, Zhang M. Clinical Characteristics of 254 COVID-19 Inpatients in Yichang, Hubei, China, and Efficacy of Integrated Chinese and Western Medicine Treatment. IJGM 2022;Volume 15:8191-8200. [DOI: 10.2147/ijgm.s391024] [Reference Citation Analysis]
9 Zhao J, Zhu J, Huang C, Zhu X, Zhu Z, Wu Q, Yuan R. Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1035151] [Reference Citation Analysis]